Literature DB >> 20093834

The Toll-like receptor 4 D299G and T399I polymorphisms are associated with Crohn's disease and ulcerative colitis: a meta-analysis.

Xiuyun Shen1, Ruihua Shi, Hongjie Zhang, Kebei Li, Yang Zhao, Ruyang Zhang.   

Abstract

BACKGROUND: Some studies have reported that Toll-like receptor 4 (TLR4) D299G and T399I polymorphisms are associated with increased Crohn's disease (CD) and ulcerative colitis (UC) risk in the Caucasian population. However, the results have been inconsistent.
METHODS: A systemic review of the published data (16 studies with 8,387 cases and 7,013 controls for D299G; 8 studies with 3,881 cases and 1,861 controls for T399I) was undertaken and a meta-analysis was performed to test whether TLR4 D299G and T399I polymorphisms were associated with CD or UC susceptibility and whether 299Gly carriage was associated with phenotypes of CD patients.
RESULTS: The TLR4 299Gly allele showed a significant association with CD and UC in the Caucasian population (OR 1.29, 95% CI 1.08-1.54, and OR 1.28, 95% CI 1.08-1.51, respectively). Similar association was detected between the T399I polymorphism and susceptibility to CD and UC (OR 1.37, 95% CI 1.12-1.68, and OR 1.46, 95% CI 1.13-1.88, respectively). However, no significant association was identified between CD phenotypes and 299Gly carriage.
CONCLUSION: The meta-analysis showed that TLR4 D299G and T399I confer a significant risk for developing CD and UC in Caucasians. Additional well-powered studies of the association between TLR4 variants and UC are needed. Copyright (c) 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20093834     DOI: 10.1159/000260417

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  26 in total

Review 1.  IBD-what role do Proteobacteria play?

Authors:  Indrani Mukhopadhya; Richard Hansen; Emad M El-Omar; Georgina L Hold
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-02-21       Impact factor: 46.802

2.  Role of gut microbiota in a zebrafish model with chemically induced enterocolitis involving toll-like receptor signaling pathways.

Authors:  Qi He; Lin Wang; Fan Wang; Qiurong Li
Journal:  Zebrafish       Date:  2014-04-23       Impact factor: 1.985

3.  Monocyte-derived dendritic cells from Crohn's disease patients exhibit decreased ability to activate T helper type 17 responses in memory cells.

Authors:  J K Nieminen; T Sipponen; M Färkkilä; O Vaarala
Journal:  Clin Exp Immunol       Date:  2014-07       Impact factor: 4.330

4.  Toll-like receptor 4 D299G polymorphism in metabolic disorders: a meta-analysis.

Authors:  F S Belforte; F Coluccio Leskow; E Poskus; A Penas Steinhardt
Journal:  Mol Biol Rep       Date:  2012-12-29       Impact factor: 2.316

5.  Escherichia coli isolates from inflammatory bowel diseases patients survive in macrophages and activate NLRP3 inflammasome.

Authors:  Marjorie De la Fuente; Luigi Franchi; Daniela Araya; David Díaz-Jiménez; Mauricio Olivares; Manuel Álvarez-Lobos; Douglas Golenbock; María-Julieta González; Francisco López-Kostner; Rodrigo Quera; Gabriel Núñez; Roberto Vidal; Marcela A Hermoso
Journal:  Int J Med Microbiol       Date:  2014-02-06       Impact factor: 3.473

6.  No evidence for involvement of the toll-like receptor (TLR) 4 gene Asp299Gly and Thr399Ile polymorphisms in susceptibility to primary gouty arthritis.

Authors:  Yu-Feng Qing; Jing-Guo Zhou; Ming Li; Wen-Guang Xie; Cui-Ping Huang; Sheng-Ping Zeng; Ling Yin
Journal:  Rheumatol Int       Date:  2012-11-15       Impact factor: 2.631

Review 7.  Toll-like receptor polymorphisms, inflammatory and infectious diseases, allergies, and cancer.

Authors:  Andrei E Medvedev
Journal:  J Interferon Cytokine Res       Date:  2013-05-15       Impact factor: 2.607

8.  Readressing the role of Toll-like receptor-4 alleles in inflammatory bowel disease: colitis, smoking, and seroreactivity.

Authors:  Anastassios C Manolakis; Andreas N Kapsoritakis; Anastasia Kapsoritaki; Elisavet K Tiaka; Konstantinos A Oikonomou; Vassilis Lotis; Dimitra Vamvakopoulou; Ioanna Davidi; Nikolaos Vamvakopoulos; Spyros P Potamianos
Journal:  Dig Dis Sci       Date:  2012-08-24       Impact factor: 3.199

9.  Targeted resequencing implicates the familial Mediterranean fever gene MEFV and the toll-like receptor 4 gene TLR4 in Behçet disease.

Authors:  Yohei Kirino; Qing Zhou; Yoshiaki Ishigatsubo; Nobuhisa Mizuki; Ilknur Tugal-Tutkun; Emire Seyahi; Yilmaz Özyazgan; Serdal Ugurlu; Burak Erer; Neslihan Abaci; Duran Ustek; Akira Meguro; Atsuhisa Ueda; Mitsuhiro Takeno; Hidetoshi Inoko; Michael J Ombrello; Colleen L Satorius; Baishali Maskeri; James C Mullikin; Hong-Wei Sun; Gustavo Gutierrez-Cruz; Yoonhee Kim; Alexander F Wilson; Daniel L Kastner; Ahmet Gül; Elaine F Remmers
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-30       Impact factor: 11.205

Review 10.  The immunogenetics of Behçet's disease: A comprehensive review.

Authors:  Masaki Takeuchi; Daniel L Kastner; Elaine F Remmers
Journal:  J Autoimmun       Date:  2015-09-05       Impact factor: 7.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.